Abstract: A board game is disclosed that includes at least two remote-controlled figures moving on a game board. Each of at least two remote-controlled figures moves to knock over an opponent's building models situated at predetermined build sites on the game board. A method of playing the game is also disclosed that includes: each player selecting a remote-controlled figure and a plurality of building models; situating each remote-controlled figure at a predetermined start site on the game board; situating the building models at the plurality of predetermined build sites on the game board; and moving each remote-controlled figure to knock down an opponent's plurality of building models.

Abstract: The invention relates to methods and systems for receiving, processing and fulfilling remotely placed orders. In one aspect, requests to place an order are received from a remote location, and based on a customer identifier included in the request, customer preference data is retrieved. An electronic selection menu based on customer preference data is transmitted to the customer, the order is received and prepared. The customer's arrival is automatically detected, and the completed order is provided to the customer.

Abstract: The present invention relates to biaryl piperidine-based renin inhibitor compounds, and their use in treating cardiovascular events and renal insufficiency.

Abstract: The invention relates to methods and systems for receiving, processing and fulfilling remotely placed orders. In one aspect, requests to place an order are received from a remote location, and based on a customer identifier included in the request, customer preference data is retrieved. An electronic selection menu based on customer preference data is transmitted to the customer, the order is received and prepared. The customer's arrival is automatically detected, and the completed order is provided to the customer.

Abstract: This invention describes a reductive amination process whereby perfluorinated ketones or ketals are combined with ?-aminoesters under basic conditions to form metal carboxylates. Diastereoselective reductions of the metal carboxylates enable access to two diastereomers, depending on the reducing conditions.

Abstract: This invention describes a reductive amination process whereby perfluorinated ketones or ketals are combined with ?-aminoesters under basic conditions to form metal carboxylates. Diastereoselective reductions of the metal carboxylates enable access to two diastereomers, depending on the reducing conditions.

Abstract: A blade assembly that can be assembled into a microkeratome which is used to cut a cornea. The blade assembly is constructed in a manner that minimizes the tolerance of the cutting depth into the cornea. The blade assembly includes a blade holder that can be pressed onto a blade. The relative position of the blade holder and the blade can be established with a tool assembly that accurately controls the distance between a reference surface of the blade holder and the cutting edge of the blade. This distance defines the cutting depth of the blade. The tool allows a manufacturer to closely control the cutting depth of the blade assembly. The blade holder may have a color or other indicator that provides an indication of the cutting depth of the blade assembly. The blade assembly may be carried in a package that has an opening to allow visual inspection of the blade. The package may have a color or other indicator that provides a visual indication of the blade cutting depth.

Abstract: The invention encompasses the novel compound of Formula I useful in the treatment of cyclooxygenase-2 mediated diseases. ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula I.

Abstract: The invention encompasses the novel compound of Formula I as well as a method of treating COX-2 mediated diseases comprising administration to a patient in need of such treatment of a non-toxic therapeutically effective amount of a compound of Formula I. ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of COX-2 mediated diseases comprising compounds of Formula I.

Abstract: The invention encompasses the novel compound of Formula I useful in the treatment of cyclooxygenase-2 mediated diseases. ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula I.